Embryonic stem cells are primed to kill themselves if damage to their DNA makes them a threat to the developing embryo. UNC researchers reveal how they do it.
A team of UNC researchers developed nanoparticle carriers to successfully deliver therapeutic doses of a cancer drug that had previously failed clinical development due to pharmacologic challenges.
The finding presents a possible explanation for why so many cancers possess not just genomic instability, but also more or less than the usual 46 DNA-containing chromosomes.
Eric Juengst, PhD, directs the UNC Center for Bioethics. He also makes armor. Yep, the kind knights would wear while protecting their king's domain.
Nutrition Research Institute receives Grand Challenges Explorations Grant for global health research
The University of North Carolina at Chapel Hill’s Nutrition Research Institute in Kannapolis is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.
UNC Cancer Care’s Bone Marrow and Stem Cell Transplantation Program is one of only 14 out of 156 centers across the country to be rated an “overperforming” center.
A UNC-led team of scientists has shown for the first time that lung cancer molecular subtypes correlate with distinct genetic alterations and with patient response to therapy.
Dr. Thomas Shea and Dr. Don Gabriel of UNC are co-authors of the study, which offers promising news about a new long-term therapy, lenalidomide, that can be used after transplantation to slow down the progression of the disease.
Susan G. Komen for the Cure® has awarded a grant of almost $900,000 to Lisa A. Carey, MD, and Gary Johnson, PhD, to research clinical applications for the first broad-based test for protein kinase activation and response to inhibitory drugs in HER2-positive breast cancer.
The professorship was established by the School of Medicine in 1988 with gifts from the Burroughs Wellcome Fund and the William A. Smith Trust of Wadesboro, N.C.
As the first two Sanders Clinician Scholars, Paul Chelminski, MD, MPH, and Samantha Meltzer-Brody, MD, MPH, will develop educational efforts to enhance supportive direct personal contact in the daily care of patients, and to teach others to do the same.
A 25-year-old Charlotte man gets a second chance at life with a profound recovery from serious lung injuries sustained in a fire that left his family homeless.
Two UNC scientists have received $2.35 million to study the question of how hepatitis C causes liver cancer.
This award is presented annually in recognition of “distinguished ministry in pastoral care” to a chaplain “who serves patients, community and colleagues with grace and innovation.”
Dr. John Buse, director of the UNC Diabetes Care Center and chair of the National Diabetes Education Program, will host a live Facebook chat on diabetes management and prevention on Tuesday, May 22.
The findings suggest that combination therapy could be a promising strategy for treating basal-like tumors.
The agreement develops partnerships in important areas of medical education and health care delivery. UNC Health Care and WakeMed also have agreed to collaboration and transparency in other areas and have agreed to resolve current disputes amicably in support of an ongoing relationship.
As a nurse, Kimberly Young works with patients in UNC's Surgery Trauma Intensive Care Unit. Outside of the hospital, Kimberly lives and works at the North Carolina Zen Center as an ordained Zen Buddhist nun.
The University of North Carolina School of Medicine and Kenan-Flagler Business School have partnered to launch a unique dual-degree program offering medical students the opportunity to earn doctor of medicine and master’s of business administration degrees in five years.
A team of researchers led by the University of North Carolina School of Medicine has demonstrated that latency develops soon after infection and slows when antiretroviral therapy is given.
UNC’s internationally renowned allergy expert to lead effort to develop new treatments and discover a cure for life-threatening food allergies.